QR678, a company dedicated to transforming hair and skin science through research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its board of advisors. Sridhar brings a wealth of expertise in biotechnology, healthcare, and aesthetics, which is expected to significantly bolster QR678’s strategic direction and market penetration.
During his tenure as Managing Director at Allergan India and South Asia, Sridhar played a pivotal role in scaling up Botox over several years, significantly expanding its market presence and transforming it into a leading product in the aesthetics industry. His leadership and strategic vision were instrumental in elevating Botox’s prominence, contributing to Allergan’s strong foothold in the market, according to QR678.
Sridhar is a distinguished figure in the medtech industry, currently being part of the Indian Institute of Technology Madras (IIT Madras) incubated enterprises, including HELYXON. His role encompasses driving strategic initiatives and leveraging his extensive experience in sales, marketing, and transformational leadership. Additionally, Sridhar is a member of the Steering Committee of HRD at the Department of Biotechnology, Ministry of Science and Technology, that provides strategic directions in biotechnology education and development. Sridhar is also an IICA certified Independent Director.
Indrajit Dutta, Vice President, QR678, said, “We are thrilled to welcome Sridhar to the QR678 Board of Advisors. His exceptional background in medtech and pharmaceuticals, coupled with his strategic vision and leadership, will be invaluable as we continue to advance our innovative hair regrowth therapy. Sridhar’s deep understanding of market dynamics, combined with his ability to steer transformative initiatives, will undoubtedly propel QR678 to new heights in both domestic and international markets.”
Sridhar Ranganathan said, “The way QR678® has progressed and its penetration in the hair growth segment is nothing short of phenomenal. What excites me about QR678 is not just its significant impact in India but its potential to revolutionize hair regrowth therapy globally. The rigorous research and academic intensity backing QR678, along with its established place in the market, make it an extraordinary journey to be part of. I look forward to collaborating with the team to support QR678’s strategic goals and further its mission of revolutionizing hair regrowth therapy.”
